Moreover, Long intergenic non-coding RNA 152 (Linc00152) as a ceRNA can confer oxaliplatin resistance via the Linc00152/miR-193a-3p/ erb-b2 receptor tyrosine kinase 4 (ERBB4)/ serine/threonine kinase 1 (AKT) signaling axis and acts as a prognostic indicator in colon cancer patients [9]. The gene discussed is ERBB4; the disease is colonic neoplasm.